Skip to content

Effect of bilinaster drop on the neonatal juandice

Effect of bilinaster drop on the neonatal hyperbilirubinemia in Mashhad Quaem Hospital 1394

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015050622115N1
Enrollment
100
Registered
2015-07-26
Start date
2015-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal jaundice. Neonatal jaundice, unspecified

Interventions

Intervention 1: In the control group, only use of standard treatment (phototherapy) . Intervention 2: In the intervention group, in addition to standard therapy,use of Bilinaster drop 5gtt/kg three t
Treatment - Other
Treatment - Drugs
In the control group, only use of standard treatment (phototherapy) .
In the intervention group, in addition to standard therapy,use of Bilinaster drop 5gtt/kg three times a day.

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Days to 14 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria: Gestational age 35-42week, birth weight over 2000 grams, total bilirubin>17mg/dl . exclusively breast feeding, lack of photo therapy or other therapies before hospitalisation, jaundice with unknown cause (idiopathic), birth Apgar score>7. Exclusion criteria: Jaundice with known cause (pathological). direct bilirubin >2, Indications for blood exchange transfusion, severe congenital defects, eclampsia / preeclampsia, asphyxia, transient or mild respiratory distress , sepsis ,hemolytic hyperbilirubinemia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Total bilirubin. Timepoint: Before the intervention, then every 12 hours for 48 hours after the intervention. Method of measurement: The hospital laboratory and by divice autoanalyzer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Ameli

Sabzevar University of Medical Sciences

ameliz1@mums.ac.ir+98 51 4444 6070

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026